Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
BJU International|August 24, 2006
Histological changes in prostate biopsies after salvage cryotherapy: effect of chronology and the method of biopsyJonathan I Izawa, J Erik Busby, Nora Morganstern, et al.Cancer Research|January 2, 2009
Aberrant activation of androgen receptor in a new neuropeptide-autocrine model of androgen-insensitive prostate cancerJoy C Yang, Joon-ha Ok, J Erik Busby, et al.Urology|March 11, 2006
Upper urinary tract tumors with nontransitional histology: a single-center experienceJ Erik Busby, Gordon A Brown, Pheroze Tamboli, et al.Urology|September 11, 2007
Ability of clinical grade to predict final pathologic stage in upper urinary tract transitional cell carcinoma: implications for therapyGordon A Brown, Surena F Matin, J Erik Busby, et al.The Prostate|October 3, 2006
Therapy of multidrug resistant human prostate tumors in the prostate of nude mice by simultaneous targeting of the epidermal growth factor receptor and vascular endothelial growth factor receptor on tumor-associated endothelial cellsJ Erik Busby, Sun-Jin Kim, Sertac Yazici, et al.Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A|December 7, 2011
Multi-institutional analysis of robotic radical cystectomy for bladder cancer: perioperative outcomes and complications in 227 patientsAngela B Smith, Mathew Raynor, Christopher L Amling, et al.The Journal of Urology|October 20, 2009
Association between lymph node density and disease specific survival in patients with penile cancerRobert S Svatek, Mark Munsell, Jordan M Kincaid, et al.BJU International|November 28, 2006
Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm?Gordon A Brown, J Erik Busby, Christopher G Wood, et al.Cancer Prevention Research (Philadelphia, Pa.)|February 2, 2012
A phase 2 cancer chemoprevention biomarker trial of isoflavone G-2535 (genistein) in presurgical bladder cancer patientsEdward Messing, Jason R Gee, Daniel R Saltzstein, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2014
Can urinary PCA3 supplement PSA in the early detection of prostate cancer?John T Wei, Ziding Feng, Alan W Partin, et al.Pageof 3